Array Technologies, Inc. Announces Updated Earnings Release

Array Technologies, Inc. Announces Updated Earnings Release

ALBUQUERQUE, N.M., March 15, 2023 (GLOBE NEWSWIRE) -- Today Array Technologies (NASDAQ: ARRY) (“Array” or “the Company”), a leading provider of tracker......

Tango Therapeutics to Highlight Preclinical Data on

Tango Therapeutics to Highlight Preclinical Data on

BOSTON, March 14, 2023 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX) today announced the acceptance of two oral and two poster......

Harpoon Therapeutics Announces Acceptance of Five Abstracts

Harpoon Therapeutics Announces Acceptance of Five Abstracts

Preclinical abstracts for investigational T cell engagers, HPN328 and HPN217, in mouse models provide further validation of Harpoon’s proprietary......

Kinnate Biopharma Inc. to Report First Clinical Data for

Kinnate Biopharma Inc. to Report First Clinical Data for

Company has initiated enrollment of patients into the monotherapy expansion cohorts Company to host a virtual investor webcast on April 17, 2023, to......

CRISPR Therapeutics to Present at the American Association

CRISPR Therapeutics to Present at the American Association

ZUG, Switzerland and BOSTON, March 14, 2023 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating......

Kura Oncology Announces Acceptance of Two Abstracts for

Kura Oncology Announces Acceptance of Two Abstracts for

– Presentations to highlight preclinical data supporting combination of FTIs with KRASG12C inhibitors and tyrosine kinase inhibitors – SAN DIEGO, March ......

Nurix Therapeutics Announces Presentations at the American

Nurix Therapeutics Announces Presentations at the American

Nurix to report additional preclinical data for its targeted BTK degraders NX-2127 and NX-5948......

Sana Biotechnology Announces the Acceptance of Four

Sana Biotechnology Announces the Acceptance of Four

Late-breaking poster presentation to highlight preclinical data demonstrating that the increased potency of CD8-targeted fusosomes enhances CAR gene......

Cullinan Oncology to Present New Preclinical Data for

Cullinan Oncology to Present New Preclinical Data for

CLN-619 is a MICA/B directed humanized IgG1 antibody being studied in a global Phase 1 clinical trial in patients with advanced solid tumors. Initial......

The Lovesac Company to Announce Fourth Quarter and Fiscal

The Lovesac Company to Announce Fourth Quarter and Fiscal

STAMFORD, Conn., March 14, 2023 (GLOBE NEWSWIRE) -- The Lovesac Company (Nasdaq: LOVE) today announced that its fourth quarter and fiscal 2023 financial......

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...
  • 44
  • menu
    menu